Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
With CDC vaccine guidance effectively on pause, top medical groups take matters into their own hands. AAFP, AAP, ACOG, and IDSA released evidence-based recommendations for flu, COVID-19, and RSV vaccines for the 2026-27 respiratory season, backed by an independent review of hundreds of peer-reviewed studies. The bottom line: vaccines still work, and no new safety concerns were found.
With the CDC's immunization recommendations effectively paused for nearly five months, four major medical organizations — AAFP, AAP, ACOG, and IDSA — stepped up to fill the void. On Wednesday, they released evidence-based vaccine guidance for the 2026-27 respiratory season covering flu, COVID-19, and RSV, backed by an independent review from the Vaccine Integrity Project (VIP), a CIDRAP initiative at the University of Minnesota.
The VIP reviewed hundreds of peer-reviewed studies published since August 2025 and found that vaccines continue to provide meaningful protection against severe illness, hospitalization, and death — with no new safety concerns identified. The reviews were simultaneously published in JAMA. The AMA also launched SpreadTheFacts.org, a centralized digital hub with immunization resources for both clinicians and patients.
Key Takeaways:
Why it matters: The breakdown of the federal vaccine guidance process has left clinicians, parents, and patients without a clear, trusted source of immunization advice heading into respiratory virus season. This independent effort aims to restore that confidence with transparent, science-driven recommendations.
